Literature DB >> 9915029

Hepatitis B vaccination of adolescent and adult high-risk groups in the United States.

E E Mast1, I T Williams, M J Alter, H S Margolis.   

Abstract

Substantial progress has been made in implementing routine infant hepatitis B vaccination in the United States. However, in 1996, an estimated 65,000 acute hepatitis B cases occurred, the majority of which were among young adults in high-risk groups. Recent surveys have found very low vaccination coverage among several high-risk groups, including men who have sex with men and patients with sexually transmitted diseases (STDs). Targeted vaccination of persons with risk factors for hepatitis B virus (HBV) infection can be provided in a variety of settings including family planning clinics, STD clinics, drug treatment centres, detention centres, jails and prisons. However, vaccination programmes have been infrequently implemented in these settings and the majority of persons with acute hepatitis B cases have had a missed opportunity for vaccination in the past. Thus, in order to accelerate elimination of HBV transmission in the United States, increased efforts are needed to implement effective hepatitis B vaccination programmes targeted to adolescents and adults in high-risk groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9915029     DOI: 10.1016/s0264-410x(98)00288-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?

Authors:  L J Yee; S D Rhodes
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

Review 2.  Increasing immunization rates among African-American adults.

Authors: 
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

3.  A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City.

Authors:  Benny J Kottiri; Samuel R Friedman; Gary L Euler; Peter L Flom; Milagros Sandoval; Alan Neaigus; Don C Des Jarlais; Jonathan M Zenilman
Journal:  J Urban Health       Date:  2005-07-20       Impact factor: 3.671

4.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

5.  Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illness.

Authors:  Eric P Slade; Stanley Rosenberg; Lisa B Dixon; Richard W Goldberg; George L Wolford; Seth Himelhoch; Stephanie Tapscott
Journal:  Psychiatr Serv       Date:  2013-02-01       Impact factor: 3.084

Review 6.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

7.  Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.

Authors:  Duncan Smith-Rohrberg Maru; Robert Douglas Bruce; Sanjay Basu; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.